https://www.sciencedaily.com/releases/2021/10/211019223140.htm

In a new Concordia-led paper published in the journal Biosensors and Bioelectronics, researchers describe a new liquid biopsy method using lab-on-a-chip technology that they believe can detect cancer before a tumour is even formed.

Using magnetic particles coated in a specially designed bonding agent, the liquid biopsy chip attracts and captures particles containing cancer-causing biomarkers. A close analysis can identify the type of cancer they are carrying. This, the researchers say, can significantly improve cancer diagnosis and treatment.